Mostrar el registro sencillo del ítem

dc.contributor.author
Seabra, Amedea B.  
dc.contributor.author
Pieretti, Joana C.  
dc.contributor.author
de Melo Santana, Bianca  
dc.contributor.author
Horue, Manuel  
dc.contributor.author
Tortella, Gonzalo R.  
dc.contributor.author
Castro, Guillermo Raul  
dc.date.available
2024-02-16T13:04:13Z  
dc.date.issued
2023-01  
dc.identifier.citation
Seabra, Amedea B.; Pieretti, Joana C.; de Melo Santana, Bianca; Horue, Manuel; Tortella, Gonzalo R.; et al.; Pharmacological applications of nitric oxide-releasing biomaterials in human skin; Elsevier Science; International Journal Of Pharmaceutics; 630; 1-2023; 1-14  
dc.identifier.issn
0378-5173  
dc.identifier.uri
http://hdl.handle.net/11336/227176  
dc.description.abstract
Nitric oxide (NO) is an important endogenous molecule that plays several roles in biological systems. NO is synthesized in human skin by three isoforms of nitric oxide synthase (NOS) and, depending on the produced NO concentration, it can actuate in wound healing, dermal vasodilation, or skin defense against different pathogens, for example. Besides being endogenously produced, NO-based pharmacological formulations have been developed for dermatological applications targeting diverse pathologies such as bacterial infection, wound healing, leishmaniasis, and even esthetic issues such as acne and skin aging. Recent strategies focus mainly on developing smart NO-releasing nanomaterials/biomaterials, as they enable a sustained and targeted NO release, promoting an improved therapeutic effect. This review aims to overview and discuss the main mechanisms of NO in human skin, the recent progress in the field of dermatological formulations containing NO, and their application in several skin diseases, highlighting promising advances and future perspectives in the field.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Elsevier Science  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
BIOMATERIALS  
dc.subject
NANOMATERIALS  
dc.subject
NITRIC OXIDE  
dc.subject
SKIN INFECTION  
dc.subject
WOUND HEALING  
dc.subject.classification
Biomateriales  
dc.subject.classification
Biotecnología de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Pharmacological applications of nitric oxide-releasing biomaterials in human skin  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-02-15T14:04:36Z  
dc.journal.volume
630  
dc.journal.pagination
1-14  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Seabra, Amedea B.. Universidad Federal do Abc; Brasil  
dc.description.fil
Fil: Pieretti, Joana C.. Universidad Federal do Abc; Brasil  
dc.description.fil
Fil: de Melo Santana, Bianca. Universidad Federal do Abc; Brasil  
dc.description.fil
Fil: Horue, Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina  
dc.description.fil
Fil: Tortella, Gonzalo R.. Universidad de La Frontera; Chile  
dc.description.fil
Fil: Castro, Guillermo Raul. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Centro de Investigación y Desarrollo en Fermentaciones Industriales. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Centro de Investigación y Desarrollo en Fermentaciones Industriales; Argentina. Universidad Federal do Abc; Brasil  
dc.journal.title
International Journal Of Pharmaceutics  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S0378517322010201  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.ijpharm.2022.122465